Skip to main content
Pulmonx Corp logo

Pulmonx Corp — Investor Relations & Filings

Ticker · LUNG ISIN · US7458481014 LEI · 549300WZMFR0ZK7RJY40 US Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US LUNG

About Pulmonx Corp

https://pulmonx.com/

Pulmonx Corp. is a medical technology company specializing in interventional pulmonology and minimally invasive treatments for severe obstructive lung diseases. The company's core offering is the Zephyr Endobronchial Valve, a non-surgical treatment for patients with severe emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD). The Zephyr Valve is a small, one-way valve implanted in the airways via a bronchoscopic procedure. It is designed to reduce hyperinflation (trapped air) in diseased parts of the lung, alleviating a primary cause of breathlessness. This one-time procedure is clinically proven to improve lung function, exercise capacity, and quality of life. Pulmonx also provides diagnostic and planning tools to support physicians in patient selection and treatment.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 9% confidence The document is a Form 8-K reporting Item 5.07: “Submission of Matters to a Vote of Security Holders,” with detailed vote counts for director elections, auditor ratification, and advisory compensation vote from the Annual Meeting. This is a post‐meeting declaration of voting results. It therefore fits the Definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-06-04 English
SD
Regulatory Filings Classification · 90% confidence The document is a completed SEC Form SD (Specialized Disclosure Report) for conflict minerals, which is a mandated regulatory filing under the Securities Exchange Act. It is not an annual or interim financial report, nor an earnings release or management presentation, but a compliance disclosure form. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-18 English
10-Q - Pulmonx Corp (0001127537) (Filer)
Interim / Quarterly Report
2026-05-04 English
ARS - Pulmonx Corp (0001127537) (Filer)
Annual Report
2026-04-22 English
DEF 14A - Pulmonx Corp (0001127537) (Filer)
Proxy Solicitation & Information Statement
2026-04-22 English
SCHEDULE 13G/A - Pulmonx Corp (0001127537) (Subject)
Major Shareholding Notification
2026-03-27 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.